Search research articles
Contact Us
Filters
Showing results (1-10 of 139) with videos related to
Page
of 14
Sort By:
Upsala Journal of Medical Sciences
|
March 24, 2016
New tools for experimental diabetes research: Cellular reprogramming and genome editing
Timo Otonkoski
Duodecim; Laaketieteellinen Aikakauskirja
|
May 3, 2011
[Neonatal diabetes mellitus]
Hanna Huopio, Timo Otonkoski
Diabetes
|
May 31, 2008
Dedifferentiation for replication of human beta-cells: a division between mice and men?
Nils Billestrup, Timo Otonkoski
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 24, 2015
Human pluripotent stem cell based islet models for diabetes research
Diego Balboa, Timo Otonkoski
Diabetologia
|
March 4, 2022
Maturation of beta cells: lessons from in vivo and in vitro models
Tom Barsby, Timo Otonkoski
Frontiers in Endocrinology
|
March 7, 2022
Stem Cell Based Models in Congenital Hyperinsulinism - Perspective on Practicalities and Possibilities
Väinö Lithovius, Timo Otonkoski
Stem Cell Research
|
June 23, 2015
Generation of iPSC line HEL47.2 from healthy human adult fibroblasts
Ras Trokovic, Jere Weltner, Timo Otonkoski
Annals of Medicine
|
November 10, 2005
Stem cells in the treatment of diabetes
Timo Otonkoski, Ru Gao, Karolina Lundin
Stem Cell Research
|
June 22, 2015
Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts
Ras Trokovic, Jere Weltner, Timo Otonkoski
Duodecim; Laaketieteellinen Aikakauskirja
|
July 6, 2004
[Replacement therapy with beta-cells: the way to treat diabetes in the future?]
Timo Otonkoski, Olle Korsgren, Kaija Salmela
Page
of 14
Search research articles
Search
Showing results (1-10 of 139) with videos related to
Sort By:
Page
of 14
Upsala Journal of Medical Sciences
|
March 24, 2016
New tools for experimental diabetes research: Cellular reprogramming and genome editing
Timo Otonkoski
Duodecim; Laaketieteellinen Aikakauskirja
|
May 3, 2011
[Neonatal diabetes mellitus]
Hanna Huopio, Timo Otonkoski
Diabetes
|
May 31, 2008
Dedifferentiation for replication of human beta-cells: a division between mice and men?
Nils Billestrup, Timo Otonkoski
Best Practice & Research. Clinical Endocrinology & Metabolism
|
December 24, 2015
Human pluripotent stem cell based islet models for diabetes research
Diego Balboa, Timo Otonkoski
Diabetologia
|
March 4, 2022
Maturation of beta cells: lessons from in vivo and in vitro models
Tom Barsby, Timo Otonkoski
Frontiers in Endocrinology
|
March 7, 2022
Stem Cell Based Models in Congenital Hyperinsulinism - Perspective on Practicalities and Possibilities
Väinö Lithovius, Timo Otonkoski
Stem Cell Research
|
June 23, 2015
Generation of iPSC line HEL47.2 from healthy human adult fibroblasts
Ras Trokovic, Jere Weltner, Timo Otonkoski
Annals of Medicine
|
November 10, 2005
Stem cells in the treatment of diabetes
Timo Otonkoski, Ru Gao, Karolina Lundin
Stem Cell Research
|
June 22, 2015
Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblasts
Ras Trokovic, Jere Weltner, Timo Otonkoski
Duodecim; Laaketieteellinen Aikakauskirja
|
July 6, 2004
[Replacement therapy with beta-cells: the way to treat diabetes in the future?]
Timo Otonkoski, Olle Korsgren, Kaija Salmela
Page
of 14